Press Release | July 8, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
Read More
News | July 6, 2020
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Read More
Press Release | July 6, 2020
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
Read More
Press Release | June 26, 2020
Aptinyx to be Added to Russell 2000® Index
Read More
